Markus Wartmann
Impact in
- Oncology top 1%
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Cell Biology top 1%
- Microtubule and mitosis dynamics
Papers in
- Oncology 50
- Cancer Treatment and Pharmacology 41
-
- Protein Kinase Regulation and GTPase Signaling 8
- Melanoma and MAPK Pathways 7
- Co-authors
- Roger J. Davis (6 shared papers)John L. Knopf (1 shared paper)Alice Lin (1 shared paper)Lih‐Ling Lin (1 shared paper)Karl‐Heinz Altmann (25 shared papers)Terence O’Reilly (7 shared papers)Doriano Fabbro (7 shared papers)Paul M.J. McSheehy (10 shared papers)
- Journals
- Cancer Research (12 papers)Journal of Biological Chemistry (5 papers)Angewandte Chemie International Edition (4 papers)ChemBioChem (3 papers)ChemMedChem (3 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Markus Wartmann
90 papers receiving 6.8k citations
Markus Wartmann's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 2.0k
- Cell Biology 899
- Molecular Biology 3.6k
- Pharmacology 668
- Cancer Research 574
Countries citing papers authored by Markus Wartmann
This map shows the geographic impact of Markus Wartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Wartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Wartmann more than expected).
Fields of papers citing papers by Markus Wartmann
This network shows the impact of papers produced by Markus Wartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Wartmann. The network helps show where Markus Wartmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Wartmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | cPLA2 is phosphorylated and activated by MAP kinase Hit paper breakdown → | 1993 | 1642 |
| 2 | 2011 | 382 | |
| 3 | CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors Hit paper breakdown → | 2014 | 357 |
| 4 | 1994 | 299 | |
| 5 | 2004 | 269 | |
| 6 | 1994 | 239 | |
| 7 | 1991 | 191 | |
| 8 | 2009 | 181 | |
| 9 | 2001 | 167 | |
| 10 | 2000 | 161 | |
| 11 | 1995 | 146 | |
| 12 | 1989 | 144 | |
| 13 | 2005 | 128 | |
| 14 | 2000 | 125 | |
| 15 | 2010 | 125 | |
| 16 | STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake. | 2003 | 114 |
| 17 | 1996 | 101 | |
| 18 | 2011 | 99 | |
| 19 | 2008 | 95 | |
| 20 | 2007 | 94 |
About Markus Wartmann
Markus Wartmann is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Cell Biology and Pharmacology, having authored 90 papers that have together received 6.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (41 papers), Synthetic Organic Chemistry Methods (25 papers), Advanced Synthetic Organic Chemistry (12 papers), Microtubule and mitosis dynamics (11 papers), Protein Kinase Regulation and GTPase Signaling (8 papers), Melanoma and MAPK Pathways (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Microbial Natural Products and Biosynthesis (6 papers). The work is most often cited by research in Oncology (2.0k citations), Cell Biology (899 citations), Molecular Biology (3.6k citations), Pharmacology (668 citations) and Cancer Research (574 citations). Markus Wartmann has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Roger J. Davis, John L. Knopf, Alice Lin, Lih‐Ling Lin, Karl‐Heinz Altmann, Terence O’Reilly, Doriano Fabbro, Paul M.J. McSheehy, Pascal Furet and Jürgen Mestan. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Angewandte Chemie International Edition, ChemBioChem and ChemMedChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.